Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Proteins
Small molecules
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 11
On the market: 2
Description:
Ascentage Pharma is a global biopharmaceutical company focused on discovering, developing, and commercializing first- and best-in-class therapies to address unmet medical needs, particularly in hematological malignancies. Lead assets olverembatinib and lisaftoclax target major hematologic cancers including chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM)....
